Form 4: BeOne Medicines GC Sells Shares After Option Exercise

BeOne Medicines' SVP and General Counsel, Chan Henry Lee, exercised stock options and subsequently sold American Depositary Shares totaling approximately $3.7 million under a Rule 10b5-1 plan.

Summary

• Chan Henry Lee, SVP, General Counsel of BeOne Medicines Ltd. (ONC), engaged in multiple transactions on October 8, 2025.
• Exercised share options to acquire a total of 124,267 Ordinary Shares (equivalent to 9,559 American Depositary Shares) at exercise prices ranging from $12.23 to $16.41 per Ordinary Share.
• Subsequently sold a total of 10,671 American Depositary Shares (ADS) at weighted average prices ranging from $347.82 to $351.1232 per ADS.
• The sales were executed pursuant to a pre-arranged Rule 10b5-1 trading plan adopted on May 14, 2025.
• Following these transactions, the reporting person beneficially owns 223,106 Ordinary Shares directly and 0 American Depositary Shares directly.
• Remaining unexercised share options include 39,624 Ordinary Shares at $14.96, 109,109 Ordinary Shares at $16.41, and 127,062 Ordinary Shares at $12.23.

Sentiment

Score: 4

Explanation: The sentiment is slightly negative due to insider selling, which can sometimes be perceived as a lack of confidence. However, the transactions were pre-planned under a Rule 10b5-1 plan and represent a routine realization of executive compensation, which mitigates strong negative sentiment.

Positives

• The officer realized significant value from their compensation by exercising options at substantially lower prices than the market price at which the shares were sold, indicating a profitable transaction for the insider.
• The transactions were conducted under a Rule 10b5-1 trading plan, which suggests pre-planning and reduces concerns about opportunistic insider trading.

Negatives

• The sale of a significant number of American Depositary Shares by a senior executive, even under a pre-arranged plan, reduces insider ownership and could be perceived as a lack of confidence by some investors.

Stakeholder Impact

• Shareholders may interpret the insider selling as a signal, potentially influencing short-term stock price movements.
• The transactions demonstrate the realization of value for the executive from their compensation package.

Next Steps

• Remaining share options will continue to vest according to their respective schedules, subject to continued service.

Key Dates

Recommendation

The filing details a routine insider transaction where a senior executive exercised stock options and subsequently sold shares under a pre-arranged 10b5-1 plan. While insider selling can sometimes be a yellow flag, the pre-planned nature and the context of executive compensation realization suggest it's not necessarily a reflection of negative company fundamentals. There are no new material operational or financial updates for the company. Therefore, a 'hold' recommendation is appropriate, advising investors to maintain their current position and monitor future company performance and insider activity.

Keywords

BeOne Medicines, ONC, Insider Trading, Form 4, Stock Options, American Depositary Shares, Rule 10b5-1, Executive Compensation, Share Sale, Option Exercise